Earnings NewsHealthcareSyros Pharmaceuticals reports Q2 resultsAug. 15, 2016 8:12 AM ETSyros Pharmaceuticals, Inc. (SYRS) StockBy: Gaurav Batavia, SA News Editor Syros Pharmaceuticals (NASDAQ:SYRS): Q2 EPS of -$5.42. Press Release Recommended For YouMore Trending NewsSee More »About SYRS StockSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield Rev Growth (YoY)Prev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgSYRS--Syros Pharmaceuticals, Inc.Trending AnalysisTrending News